Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

713.71
-1.4900-0.21%
Post-market: 714.000.2900+0.04%19:59 EDT
Volume:2.64M
Turnover:1.88B
Market Cap:676.41B
PE:60.95
High:719.64
Open:710.00
Low:709.00
Close:715.20
Loading ...

Eli Lilly Exec Says Announced Tariffs Currently in Effect Do Not Materially Change Co's 2025 Financial Outlook - Conf Call

THOMSON REUTERS
·
01 May

Lilly Exec Says Expect US Regulatory Action for Modified Dosing Regime for Alzheimer's Drug Kisunla in the Next Few Months

THOMSON REUTERS
·
01 May

Lilly Exec Says Plans to Start a New Late-Stage Trial for Its Drug Retatrutide in Patients With Obesity and Chronic Low Back Pain

THOMSON REUTERS
·
01 May

Lilly Exec Says Recently Initiated Limited Mounjaro Launch in China, Expect to to Gradually Increase Launch in H2 as Supply Becomes Available

THOMSON REUTERS
·
01 May

Lilly Exec Says Expansion of Tariffs in Other Geographies or Increases in Retaliatory Tariffs Would Have a Negative Effect on Co, Industry

THOMSON REUTERS
·
01 May

Lilly Exec Says Co Has Withdrawn US Application for Heart Failure With Preserved Ejection Fraction Indication for Tirzepatide

THOMSON REUTERS
·
01 May

Stock Track | Eli Lilly Plunges 7.29% Pre-Market on Lowered Guidance and CVS Health's Wegovy Deal

Stock Track
·
01 May

Pharma Stocks Sank. Eli Lilly Fell 7%; Moderna Fell 5%; Novavax And BioNTech Fell 4%; Viking Fell 2%

Tiger Newspress
·
01 May

Mounjaro Maker Eli Lilly Clocks 45% Jump In Q1 Revenue, Cuts 2025 Profit Outlook But Not Due To Tariffs

Benzinga
·
01 May

Eli Lilly Shares Down 5.8% After CVS Health to Drop Co's Obesity Drug Zepbound Coverage

THOMSON REUTERS
·
01 May

Eli Lilly and Co reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Here's What Key Metrics Tell Us About Lilly (LLY) Q1 Earnings

Zacks
·
01 May

Eli Lilly Lowers 2025 Earnings Outlook Despite Stronger-Than-Expected First-Quarter Results

MT Newswires
·
01 May

Lower Taxes Could Bring More Drug Production to U.S., Says Eli Lilly CEO -- WSJ

Dow Jones
·
01 May

BUZZ-Eli Lilly falls after weight-loss drug sales miss expectations

Reuters
·
01 May

Eli Lilly (LLY) Q1 Earnings Lag Estimates

Zacks
·
01 May

Eli Lilly (NYSE:LLY) Beats Q1 Sales Targets

StockStory
·
01 May

Eli Lilly cuts FY25 adjusted EPS view to $20.78-$22.28 from $22.50-$24.00

TIPRANKS
·
01 May

Stock Track | Eli Lilly Plunges 5.32% Pre-Market on Lowered Earnings Guidance and Zepbound Sales Miss

Stock Track
·
01 May

Eli Lilly Shares Extend Premarket Losses, Last Down 4.8%

THOMSON REUTERS
·
01 May